secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001326190-23-000040
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune 2023 annual meeting results: all director nominees elected, say-on-pay approved
--------------------------------------------------------------------------------

- All 9 director nominees elected; highest vote for was 21.9M, lowest 19.4M.
- Say-on-pay advisory vote passed: 16.8M for, 5.2M against, 12.4M broker non-votes.
- Stockholders selected 1-year frequency for future say-on-pay votes (21.6M for 1-year).
- Ernst & Young ratified as auditor for FY2023 with 34.3M for, 153K against.
- Adjournment proposal authorized with 27.7M for vs 6.7M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619023000040/0001326190-23-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619023000040/alt-20230928x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-23-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer